Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Thyroid Carcinoma, Anaplastic × zimberelimab × NET × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 NET 1 Head & Neck 1 Gynecologic 1 Gastrointestinal 1 Endocrine 1

Conditions

Thyroid Carcinoma, Anaplastic 1 Thymoma 1 Gestational Trophoblastic Disease 1 Gastro-enteropancreatic neuroendocrine tumor 1 Carcinoid Tumor 1

Interventions

zimberelimab 1 tislelizumab 1 surufatinib 1 cabozantinib 1 atezolizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06790706 2025-10-06

IMMUNORARE5

Hospices Civils de Lyon

Phase 2 Recruiting

EndocrineGastrointestinalGynecologicHead & NeckNETThoracic

Gastro-enteropancreatic neuroendocrine tumor, Carcinoid Tumor, Thymoma, Gestational Trophoblastic Disease, Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡